Expression of Cancer-Testis Genes in Brain Tumors
Journal of Korean Neurosurgical Society
;
: 190-193, 2008.
Article
in English
| WPRIM
| ID: wpr-73779
ABSTRACT
OBJECTIVE:
Cancer-testis (CT) genes are considered promising candidates for immunotherapeutic approaches. The aim of this study was to investigate which CT genes should be targeted in immunotherapy for brain tumors.METHODS:
We investigated the expression of 6 CT genes (MAGE-E1, SOX-6, SCP-1, SSX-2, SSX-4, and HOMTES-85) using reverse-transcription polymerase chain reaction in 26 meningiomas and 32 other various brain tumor specimens, obtained from the patients during tumor surgery from 2000 to 2005.RESULTS:
The most frequently expressed CT genes of meningiomas were MAGE-E1, which were found in 22/26 (85%) meningioma samples, followed by SOX-6 (9/26 or 35%). Glioblastomas were most frequently expressed SOX-6 (6/7 or 86%), MAGE-E1 (5/7 or 71%), followed by SSX-2 (2/7 or 29%) and SCP-1 (1/7 or 14%). However, 4 astrocytomas, 3 anaplastic astrocytomas, and 3 oligodendroglial tumors only expressed MAGE-E1 and SOX-6. Schwannomas also expressed SOX-6 (5/6 or 83%), MAGE-E1 (4/6 or 67%), and SCP-1 (2/6 or 33%).CONCLUSION:
The data presented here suggest that MAGE-E1 and SOX-6 genes are expressed in a high percentage of human central nervous system tumors, which implies the CT genes could be the potential targets of immunotherapy for human central nervous system tumors.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Astrocytoma
/
Saccharin
/
Brain
/
Brain Neoplasms
/
Polymerase Chain Reaction
/
Central Nervous System Neoplasms
/
Glioblastoma
/
Immunotherapy
/
Acetaminophen
/
Meningioma
Limits:
Humans
Language:
English
Journal:
Journal of Korean Neurosurgical Society
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS